National Research Corporation (NRC)
USD 11.72
(-5.52%)
USD 11.72
(-5.52%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 86.66 Million USD | -8.31% |
| 2022 | 94.51 Million USD | -1.13% |
| 2021 | 95.6 Million USD | 13.69% |
| 2020 | 84.09 Million USD | 3.12% |
| 2019 | 81.54 Million USD | 13.09% |
| 2018 | 72.1 Million USD | 5.28% |
| 2017 | 68.49 Million USD | 7.34% |
| 2016 | 63.8 Million USD | 10.52% |
| 2015 | 57.73 Million USD | 1.08% |
| 2014 | 57.11 Million USD | 6.27% |
| 2013 | 53.74 Million USD | 5.47% |
| 2012 | 50.96 Million USD | 8.2% |
| 2011 | 47.1 Million USD | 21.51% |
| 2010 | 38.76 Million USD | 17.05% |
| 2009 | 33.11 Million USD | 20.86% |
| 2008 | 27.4 Million USD | 1.03% |
| 2007 | 27.12 Million USD | 11.5% |
| 2006 | 24.32 Million USD | 29.43% |
| 2005 | 18.79 Million USD | 11.78% |
| 2004 | 16.81 Million USD | 12.9% |
| 2003 | 14.89 Million USD | 16.06% |
| 2002 | 12.83 Million USD | 33.46% |
| 2001 | 9.61 Million USD | 4.55% |
| 2000 | 9.19 Million USD | 29.53% |
| 1999 | 7.1 Million USD | -14.46% |
| 1998 | 8.3 Million USD | -8.79% |
| 1997 | 9.1 Million USD | 31.88% |
| 1996 | 6.9 Million USD | 27.26% |
| 1995 | 5.42 Million USD | 43.14% |
| 1994 | 3.78 Million USD | 119.21% |
| 1993 | 1.72 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 20.01 Million USD | -12.16% |
| 2024 Q2 | 20.08 Million USD | 0.38% |
| 2024 Q3 | 18.96 Million USD | 2.13% |
| 2023 Q3 | 23.31 Million USD | 2.01% |
| 2023 Q4 | 22.77 Million USD | -2.29% |
| 2023 FY | 86.66 Million USD | -8.31% |
| 2023 Q1 | 22.19 Million USD | -8.13% |
| 2023 Q2 | 22.85 Million USD | 2.97% |
| 2022 Q4 | 24.15 Million USD | 4.27% |
| 2022 Q2 | 23.53 Million USD | -0.54% |
| 2022 FY | 94.51 Million USD | -1.13% |
| 2022 Q1 | 23.66 Million USD | -1.94% |
| 2022 Q3 | 23.16 Million USD | -1.56% |
| 2021 Q1 | 23.52 Million USD | 7.14% |
| 2021 FY | 95.6 Million USD | 13.69% |
| 2021 Q2 | 23.88 Million USD | 1.55% |
| 2021 Q4 | 24.13 Million USD | 0.3% |
| 2021 Q3 | 24.06 Million USD | 0.72% |
| 2020 Q1 | 21.31 Million USD | -0.67% |
| 2020 Q2 | 19.53 Million USD | -8.36% |
| 2020 Q3 | 21.28 Million USD | 8.99% |
| 2020 Q4 | 21.95 Million USD | 3.14% |
| 2020 FY | 84.09 Million USD | 3.12% |
| 2019 Q1 | 19.82 Million USD | 5.76% |
| 2019 Q2 | 19.9 Million USD | 0.41% |
| 2019 Q3 | 20.35 Million USD | 2.25% |
| 2019 Q4 | 21.45 Million USD | 5.41% |
| 2019 FY | 81.54 Million USD | 13.09% |
| 2018 Q4 | 18.74 Million USD | 2.82% |
| 2018 Q3 | 18.23 Million USD | 7.12% |
| 2018 FY | 72.1 Million USD | 5.28% |
| 2018 Q2 | 17.02 Million USD | -6.0% |
| 2018 Q1 | 18.1 Million USD | 3.27% |
| 2017 Q1 | 17.77 Million USD | 7.52% |
| 2017 FY | 68.49 Million USD | 7.34% |
| 2017 Q4 | 17.53 Million USD | 5.1% |
| 2017 Q3 | 16.68 Million USD | 1.14% |
| 2017 Q2 | 16.49 Million USD | -7.2% |
| 2016 Q3 | 15.56 Million USD | 1.2% |
| 2016 FY | 63.8 Million USD | 10.52% |
| 2016 Q2 | 15.38 Million USD | -5.82% |
| 2016 Q1 | 16.33 Million USD | 8.87% |
| 2016 Q4 | 16.53 Million USD | 6.22% |
| 2015 Q4 | 15 Million USD | 5.35% |
| 2015 Q2 | 14.02 Million USD | -3.09% |
| 2015 Q1 | 14.47 Million USD | 1.37% |
| 2015 FY | 57.73 Million USD | 1.08% |
| 2015 Q3 | 14.23 Million USD | 1.53% |
| 2014 Q4 | 14.27 Million USD | 2.61% |
| 2014 FY | 57.11 Million USD | 6.27% |
| 2014 Q3 | 13.91 Million USD | 5.18% |
| 2014 Q2 | 13.22 Million USD | -15.75% |
| 2014 Q1 | 15.7 Million USD | 18.27% |
| 2013 Q2 | 12.85 Million USD | -12.31% |
| 2013 Q1 | 14.66 Million USD | 13.93% |
| 2013 FY | 53.74 Million USD | 5.47% |
| 2013 Q4 | 13.27 Million USD | 2.47% |
| 2013 Q3 | 12.95 Million USD | 0.77% |
| 2012 Q2 | 11.99 Million USD | -10.96% |
| 2012 Q3 | 12.61 Million USD | 5.15% |
| 2012 FY | 50.96 Million USD | 8.2% |
| 2012 Q4 | 12.86 Million USD | 1.99% |
| 2012 Q1 | 13.47 Million USD | 12.92% |
| 2011 Q1 | 13.03 Million USD | 35.51% |
| 2011 Q2 | 11.05 Million USD | -15.17% |
| 2011 Q3 | 11.07 Million USD | 0.2% |
| 2011 Q4 | 11.93 Million USD | 7.73% |
| 2011 FY | 47.1 Million USD | 21.51% |
| 2010 FY | 38.76 Million USD | 17.05% |
| 2010 Q1 | 10.91 Million USD | 31.57% |
| 2010 Q2 | 8.26 Million USD | -24.3% |
| 2010 Q3 | 9.96 Million USD | 20.65% |
| 2010 Q4 | 9.61 Million USD | -3.51% |
| 2009 Q2 | 7.29 Million USD | -22.97% |
| 2009 FY | 33.11 Million USD | 20.86% |
| 2009 Q4 | 8.29 Million USD | 2.78% |
| 2009 Q3 | 8.07 Million USD | 10.71% |
| 2009 Q1 | 9.46 Million USD | 47.33% |
| 2008 Q1 | 7.52 Million USD | 30.59% |
| 2008 FY | 27.4 Million USD | 1.03% |
| 2008 Q2 | 6.58 Million USD | -12.57% |
| 2008 Q4 | 6.42 Million USD | -6.5% |
| 2008 Q3 | 6.87 Million USD | 4.4% |
| 2007 Q1 | 6.75 Million USD | 18.26% |
| 2007 FY | 27.12 Million USD | 11.5% |
| 2007 Q4 | 5.76 Million USD | -28.15% |
| 2007 Q3 | 8.02 Million USD | 21.93% |
| 2007 Q2 | 6.57 Million USD | -2.62% |
| 2006 Q2 | 5.68 Million USD | 5.71% |
| 2006 Q1 | 5.37 Million USD | 13.04% |
| 2006 Q3 | 7.55 Million USD | 32.88% |
| 2006 Q4 | 5.71 Million USD | -24.35% |
| 2006 FY | 24.32 Million USD | 29.43% |
| 2005 Q1 | 3.84 Million USD | 2.59% |
| 2005 Q2 | 4.07 Million USD | 5.97% |
| 2005 Q4 | 4.75 Million USD | -22.21% |
| 2005 FY | 18.79 Million USD | 11.78% |
| 2005 Q3 | 6.11 Million USD | 49.98% |
| 2004 Q4 | 3.74 Million USD | -27.13% |
| 2004 Q3 | 5.14 Million USD | 40.8% |
| 2004 Q2 | 3.65 Million USD | -14.27% |
| 2004 Q1 | 4.26 Million USD | 6.74% |
| 2004 FY | 16.81 Million USD | 12.9% |
| 2003 Q1 | 3.24 Million USD | -10.65% |
| 2003 FY | 14.89 Million USD | 16.06% |
| 2003 Q4 | 3.99 Million USD | -4.82% |
| 2003 Q3 | 4.19 Million USD | 21.24% |
| 2003 Q2 | 3.46 Million USD | 6.75% |
| 2002 Q4 | 3.62 Million USD | -7.64% |
| 2002 Q3 | 3.92 Million USD | 30.1% |
| 2002 Q1 | 2.25 Million USD | -5.1% |
| 2002 FY | 12.83 Million USD | 33.46% |
| 2002 Q2 | 3.02 Million USD | 33.98% |
| 2001 Q3 | 3.41 Million USD | 104.44% |
| 2001 FY | 9.61 Million USD | 4.55% |
| 2001 Q4 | 2.37 Million USD | -30.47% |
| 2001 Q1 | 2.1 Million USD | -24.92% |
| 2001 Q2 | 1.67 Million USD | -20.47% |
| 2000 Q3 | 2.31 Million USD | 6.28% |
| 2000 FY | 9.19 Million USD | 29.53% |
| 2000 Q4 | 2.79 Million USD | 20.68% |
| 2000 Q2 | 2.18 Million USD | 14.99% |
| 2000 Q1 | 1.89 Million USD | -27.02% |
| 1999 Q2 | 1.3 Million USD | 18.18% |
| 1999 Q1 | 1.1 Million USD | -47.62% |
| 1999 Q4 | 2.6 Million USD | 23.81% |
| 1999 Q3 | 2.1 Million USD | 61.54% |
| 1999 FY | 7.1 Million USD | -14.46% |
| 1998 Q4 | 2.1 Million USD | -4.55% |
| 1998 Q3 | 2.2 Million USD | 10.0% |
| 1998 Q2 | 2 Million USD | 5.26% |
| 1998 Q1 | 1.9 Million USD | -58.7% |
| 1998 FY | 8.3 Million USD | -8.79% |
| 1997 FY | 9.1 Million USD | 31.88% |
| 1997 Q1 | 3.4 Million USD | 0.0% |
| 1997 Q2 | 3.5 Million USD | 2.94% |
| 1997 Q4 | 4.6 Million USD | -2.13% |
| 1997 Q3 | 4.7 Million USD | 34.29% |
| 1996 FY | 6.9 Million USD | 27.26% |
| 1995 FY | 5.42 Million USD | 43.14% |
| 1994 FY | 3.78 Million USD | 119.21% |
| 1993 FY | 1.72 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| CareCloud, Inc. | 46.24 Million USD | -87.418% |
| Augmedix, Inc. | 21.52 Million USD | -302.611% |
| BrightSpring Health Services, Inc. Common Stock | 1.43 Billion USD | 93.955% |
| CareCloud, Inc. | 46.24 Million USD | -87.418% |
| HealthEquity, Inc. | 622.63 Million USD | 86.081% |
| iCoreConnect Inc. | 6.12 Million USD | -1315.547% |
| Inovalon Holdings, Inc. | 499.7 Million USD | 82.656% |
| Nutex Health, Inc. | 34.77 Million USD | -149.225% |
| Omnicell, Inc. | 499.92 Million USD | 82.664% |
| OneMedNet Corporation | -127.9 Thousand USD | 67860.751% |
| Progyny, Inc. | 238.79 Million USD | 63.708% |
| Renalytix Plc | 156 Thousand USD | -55455.128% |
| Schrödinger, Inc. | 140.69 Million USD | 38.4% |
| Simulations Plus, Inc. | 43.15 Million USD | -100.844% |
| SOPHiA GENETICS SA | 42.91 Million USD | -101.957% |
| Streamline Health Solutions, Inc. | 11.54 Million USD | -650.81% |
| Ontrak, Inc. | 8.8 Million USD | -884.841% |
| GE HealthCare Technologies Inc. | 7.92 Billion USD | 98.906% |
| Sharecare, Inc. | 129.49 Million USD | 33.076% |
| Aclarion, Inc. | -324.00 USD | 26748865.432% |
| CareMax, Inc. | 13.9 Million USD | -523.452% |
| Bullfrog AI Holdings, Inc. Common Stock | 59.8 Thousand USD | -144826.421% |
| Forian Inc. | 15 Million USD | -477.608% |
| Bullfrog AI Holdings, Inc. Warrants | 59.8 Thousand USD | -144826.421% |
| HeartBeam, Inc. | - USD | -Infinity% |
| GeneDx Holdings Corp. | 60.62 Million USD | -42.961% |
| SCWorx Corp. | 1.26 Million USD | -6729.052% |
| Minerva Surgical, Inc. | 27.24 Million USD | -218.134% |
| Definitive Healthcare Corp. | 203.93 Million USD | 57.503% |
| 10x Genomics, Inc. | 409.31 Million USD | 78.826% |
| Zhongchao Inc. | 8.51 Million USD | -918.14% |
| Accolade, Inc. | 192.06 Million USD | 54.876% |
| MSP Recovery, Inc. | 5.56 Million USD | -1458.741% |
| R1 RCM Inc. | 484.5 Million USD | 82.112% |
| Spok Holdings, Inc. | 112.2 Million USD | 22.762% |
| Privia Health Group, Inc. | 161.5 Million USD | 46.337% |
| EUDA Health Holdings Limited | 842.07 Thousand USD | -10191.957% |
| TruBridge, Inc. | 163.56 Million USD | 47.015% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 1.43 Billion USD | 93.955% |
| Sharecare, Inc. | 129.49 Million USD | 33.076% |
| Health Catalyst, Inc. | 131.83 Million USD | 34.261% |
| GoodRx Holdings, Inc. | 683.34 Million USD | 87.317% |
| Premier, Inc. | 840.73 Million USD | 89.692% |
| HealthStream, Inc. | 184.04 Million USD | 52.91% |
| Certara, Inc. | 213.31 Million USD | 59.372% |
| GeneDx Holdings Corp. | 60.62 Million USD | -42.961% |
| Ontrak, Inc. | 8.8 Million USD | -884.841% |
| SHL Telemedicine Ltd. | 25.26 Million USD | -243.082% |
| CareCloud, Inc. | 46.24 Million USD | -87.418% |
| EUDA Health Holdings Limited | 842.07 Thousand USD | -10191.957% |
| HeartBeam, Inc. | - USD | -Infinity% |
| Mangoceuticals, Inc. | 431.5 Thousand USD | -19984.774% |
| CareMax, Inc. | 13.9 Million USD | -523.452% |
| Healthcare Triangle, Inc. | 6.77 Million USD | -1178.825% |
| Aclarion, Inc. | -324.00 USD | 26748865.432% |
| OptimizeRx Corporation | 42.89 Million USD | -102.019% |